Your browser doesn't support javascript.
loading
Studies on enmetazobactam clarify mechanisms of widely used ß-lactamase inhibitors.
Lang, Pauline A; Raj, Ritu; Tumber, Anthony; Lohans, Christopher T; Rabe, Patrick; Robinson, Carol V; Brem, Jürgen; Schofield, Christopher J.
Affiliation
  • Lang PA; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford OX1 3TA, United Kingdom.
  • Raj R; Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford OX1 3TA, United Kingdom.
  • Tumber A; Physical and Theoretical Chemistry Laboratory, Department of Chemistry, University of Oxford, Oxford OX1 3TA, United Kingdom.
  • Lohans CT; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford OX1 3QU, United Kingdom.
  • Rabe P; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford OX1 3TA, United Kingdom.
  • Robinson CV; Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford OX1 3TA, United Kingdom.
  • Brem J; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford OX1 3TA, United Kingdom.
  • Schofield CJ; Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford OX1 3TA, United Kingdom.
Proc Natl Acad Sci U S A ; 119(18): e2117310119, 2022 05 03.
Article in En | MEDLINE | ID: mdl-35486701

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azabicyclo Compounds / Beta-Lactamase Inhibitors Type of study: Prognostic_studies Language: En Journal: Proc Natl Acad Sci U S A Year: 2022 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azabicyclo Compounds / Beta-Lactamase Inhibitors Type of study: Prognostic_studies Language: En Journal: Proc Natl Acad Sci U S A Year: 2022 Type: Article Affiliation country: United kingdom